The IRIS (Insulin Resistance Intervention after Stroke) trial: A new perspective on pioglitazone

J Diabetes. 2016 Sep;8(5):607-9. doi: 10.1111/1753-0407.12399. Epub 2016 Jun 8.
No abstract available

MeSH terms

  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin Resistance*
  • Ischemic Attack, Transient / drug therapy*
  • Ischemic Attack, Transient / prevention & control
  • Multicenter Studies as Topic
  • Myocardial Infarction / prevention & control
  • Pioglitazone
  • Randomized Controlled Trials as Topic
  • Stroke / drug therapy*
  • Stroke / prevention & control
  • Thiazolidinediones / therapeutic use*
  • Weight Gain / drug effects

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Pioglitazone